MacKenzie Realty Capital, Inc. (MKZR)
CIK 1550913 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 2.3M shares as of May 15, 2026 (10-Q). Share count fell from 15.8M to 1.8M between May 15, 2025 and Sep 29, 2025, a pattern consistent with a reverse split (roughly 1-for-9); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Self-funding
generates cash
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Common Stock Warrants | 423,944.85 | $17.1 | — | — |
| Series B Common Stock Warrants | 282,629.9 | $17.1 | 5y | — |
| Series A Common Stock Warrants | 141,314.95 | $17.1 | 1.5y | — |
| Pre Funded Warrants | 129,226.5 | $0.001 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed May 15, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 423,944.85 underlying shares, as reported Mar 31, 2026 (10-Q).
Rough fully diluted estimate: 2.7M = 2.3M O/S + 423,944.85 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed May 15, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 2.3M | May 15, 2026 |
| + Common Stock Warrants (if exercised) | 423,944.85 | Feb 28, 2025 |
| + Series B Common Stock Warrants (if exercised) | 282,629.9 | Mar 31, 2026 |
| + Series A Common Stock Warrants (if exercised) | 141,314.95 | Mar 31, 2026 |
| + Pre Funded Warrants (if exercised) | 129,226.5 | Jun 30, 2025 |
| Fully diluted estimate | 3.2M | +43.3% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $75.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 0 executed · 0 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full MKZR workspace